Fernando Velayos

6.6k total citations · 2 hit papers
92 papers, 3.8k citations indexed

About

Fernando Velayos is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Fernando Velayos has authored 92 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Genetics, 57 papers in Epidemiology and 25 papers in Surgery. Recurrent topics in Fernando Velayos's work include Inflammatory Bowel Disease (65 papers), Microscopic Colitis (52 papers) and Colorectal Cancer Screening and Detection (23 papers). Fernando Velayos is often cited by papers focused on Inflammatory Bowel Disease (65 papers), Microscopic Colitis (52 papers) and Colorectal Cancer Screening and Detection (23 papers). Fernando Velayos collaborates with scholars based in United States, Canada and United Kingdom. Fernando Velayos's co-authors include William J. Sandborn, Jonathan P. Terdiman, Judith Walsh, Edward V. Loftus, William J. Tremaine, Tine Jess, Alan R. Zinsmeister, William S. Harmsen, James D. Lewis and Lisa J. Herrinton and has published in prestigious journals such as Gastroenterology, Radiology and The Journal of Pediatrics.

In The Last Decade

Fernando Velayos

84 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

2019 228 citations Adam S. Cheifetz, Gil Melmed et al. Clinical Gastroenterology and Hepatology profile →
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis

2023 71 citations Siddharth Singh, Ashwin N. Ananthakrishnan et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fernando Velayos United States	29	2.5k	1.9k	1.1k	934	566	92	3.8k
Sang Hyoung Park South Korea	37	2.5k 1.0×	2.0k 1.0×	1.7k 1.5×	560 0.6×	639 1.1×	252	4.5k
Jean–Marc Phelip France	31	1.3k 0.5×	1.2k 0.6×	830 0.8×	1.3k 1.4×	595 1.1×	141	3.2k
Jostein Sauar Norway	26	2.5k 1.0×	2.1k 1.1×	1.2k 1.1×	785 0.8×	280 0.5×	48	3.6k
Tom Öresland Sweden	36	3.6k 1.4×	2.6k 1.4×	3.0k 2.7×	1.1k 1.1×	580 1.0×	99	6.0k
Michael Safdi United States	25	2.0k 0.8×	1.5k 0.8×	1.3k 1.2×	969 1.0×	599 1.1×	45	3.8k
Ren Mao China	33	1.9k 0.7×	1.4k 0.7×	1.1k 1.0×	543 0.6×	585 1.0×	141	4.0k
Marco Daperno Italy	29	3.4k 1.3×	2.6k 1.4×	1.7k 1.5×	617 0.7×	569 1.0×	113	4.2k
Ambrogio Orlando Italy	31	2.5k 1.0×	2.7k 1.4×	1.2k 1.1×	359 0.4×	591 1.0×	152	4.5k
Ole Høie Norway	21	1.9k 0.8×	1.7k 0.9×	1.0k 0.9×	480 0.5×	192 0.3×	36	2.7k
Mark T. Osterman United States	31	2.1k 0.9×	1.7k 0.9×	781 0.7×	195 0.2×	707 1.2×	157	3.2k

Countries citing papers authored by Fernando Velayos

Since Specialization

Citations

This map shows the geographic impact of Fernando Velayos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Velayos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Velayos more than expected).

Fields of papers citing papers by Fernando Velayos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Velayos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Velayos. The network helps show where Fernando Velayos may publish in the future.

Co-authorship network of co-authors of Fernando Velayos

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Velayos. A scholar is included among the top collaborators of Fernando Velayos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Velayos. Fernando Velayos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hirschtritt, Matthew E., et al.. (2023). Psychiatric Diagnoses, Medication, and Service Use Among Patients Who Receive Emergency Care for Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. 30(9). 1619–1622. 1 indexed citations

Ananthakrishnan, Ashwin N., Jeremy Adler, Karen A. Chachu, et al.. (2023). AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease. Gastroenterology. 165(6). 1367–1399. 43 indexed citations

Shirazi, Aida, et al.. (2023). Increased Risk of Hospitalization, Surgery, and Venous Thromboembolism Among Patients With Inflammatory Bowel Disease and Malnutrition in a Large, Community-Based Health Care System. The American Journal of Gastroenterology. 118(8). 1395–1401. 2 indexed citations

Lee, Jeffrey K., et al.. (2023). The Contemporary Probability of Occult Colorectal Cancer in Patients With Colitis-Related Dysplasia Undergoing Colectomy. The American Journal of Gastroenterology. 118(8). 1453–1456.

Cleveland, Noa Krugliak, Brian Bressler, Corey A. Siegel, et al.. (2022). A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities. Gastroenterology. 163(6). 1505–1509. 6 indexed citations

Velayos, Fernando, et al.. (2021). Prior Immunosuppressive Therapy and Severe Illness Among Patients Diagnosed with SARS-CoV-2: a Community-Based Study. Journal of General Internal Medicine. 36(12). 3794–3801. 10 indexed citations

Velayos, Fernando, et al.. (2020). Going Viral: Management of IBD in the Era of the COVID-19 Pandemic. Digestive Diseases and Sciences. 65(6). 1571–1575. 9 indexed citations

Velayos, Fernando, et al.. (2020). Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences. 65(11). 3111–3115. 6 indexed citations

Regueiro, Miguel, Fernando Velayos, Julia B. Greer, et al.. (2016). American Gastroenterological Association Institute Technical Review on the Management of Crohn’s Disease After Surgical Resection. Gastroenterology. 152(1). 277–295.e3. 98 indexed citations

10.

Nett, Andrew, Fernando Velayos, & Kenneth R. McQuaid. (2014). Quality Bowel Preparation for Surveillance Colonoscopy in Patients with Inflammatory Bowel Disease Is a Must. Gastrointestinal Endoscopy Clinics of North America. 24(3). 379–392. 21 indexed citations

11.

Li, Dan, Fernando Velayos, Liyan Liu, et al.. (2013). Racial and Ethnic Differences in Health Care Utilization and Outcomes Among Ulcerative Colitis Patients in an Integrated Health-Care Organization. Digestive Diseases and Sciences. 59(2). 287–294. 25 indexed citations

12.

Velayos, Fernando, et al.. (2011). Durability of Infliximab Dose Intensification in Crohn’s Disease. Digestive Diseases and Sciences. 57(4). 1013–1019. 18 indexed citations

13.

Baños, Fabián Juliao, et al.. (2010). Phenotypes and natural history of Inflammatory Bowel Disease (IBD) in a referral population in Medellín, Colombia. Revista Colombiana de Gastroenterología. 25(3). 240–251. 5 indexed citations

14.

Baños, Fabián Juliao, et al.. (2010). Fenotipo e historia natural de la enfermedad inflamatoria intestinal en un centro de referencia en Medellín-Colombia. Redalyc (Universidad Autónoma del Estado de México). 25(3). 240–251. 19 indexed citations

15.

Melmed, Gil, Brennan Spiegel, Brian Bressler, et al.. (2010). The Appropriateness of Concomitant Immunomodulators With Anti–Tumor Necrosis Factor Agents for Crohn's Disease: One Size Does Not Fit All. Clinical Gastroenterology and Hepatology. 8(8). 655–659. 39 indexed citations

16.

Abramson, Oren, William Mow, G. Allen Finley, et al.. (2010). Incidence, Prevalence, and Time Trends of Pediatric Inflammatory Bowel Disease in Northern California, 1996 to 2006. The Journal of Pediatrics. 157(2). 233–239.e1. 107 indexed citations

17.

Herrinton, Lisa J., Liyan Liu, Bruce Fireman, et al.. (2009). Time Trends in Therapies and Outcomes for Adult Inflammatory Bowel Disease, Northern California, 1998–2005. Gastroenterology. 137(2). 502–511. 80 indexed citations

18.

Sparrow, Miles, Peter M. Irving, Leonard Baidoo, et al.. (2008). Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group.. PubMed Central. 4(10). 713–20. 1 indexed citations

19.

Truta, Brindusa, Yunn-Yi Chen, Amie Blanco, et al.. (2008). Tumor histology helps to identify Lynch syndrome among colorectal cancer patients. Familial Cancer. 7(3). 267–274. 10 indexed citations

20.

Jess, Tine, Edward V. Loftus, Fernando Velayos, et al.. (2007). Risk Factors for Colorectal Neoplasia in Inflammatory Bowel Disease: A Nested Case?Control Study From Copenhagen County, Denmark and Olmsted County, Minnesota. The American Journal of Gastroenterology. 102(4). 829–836. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact